LifeMD(US:LFMD) Globenewswireยท2025-09-21 11:49Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against LifeMD, Inc. due to allegations of violations of federal securities laws, particularly concerning misleading statements and financial guidance [4][6]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses exceeding $75,000 in LifeMD between May 7, 2025, and August 5, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against LifeMD, with a deadline of October 27, 2025, for investors to seek the role of lead plaintiff [4][8]. Group 2: Allegations Against LifeMD - The complaint alleges that LifeMD and its executives materially overstated the company's competitive position and were reckless in raising the 2025 guidance without properly accounting for rising customer acquisition costs [6]. - LifeMD's revised guidance announced on August 5, 2025, projected total revenue in the range of $250 to $255 million, down from previous guidance of $268 to $275 million, leading to a 44.8% stock price drop on August 6, 2025 [7].